MPS Pharm - ClearVue Technologies Founder Chairman
CVUEF Stock | USD 0.16 0.03 23.08% |
Insider
MPS Pharm is Founder Chairman of ClearVue Technologies Limited
Phone | 61 8 9482 0500 |
Web | https://www.clearvuepv.com |
ClearVue Technologies Management Efficiency
The company has return on total asset (ROA) of (0.1312) % which means that it has lost $0.1312 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2112) %, meaning that it generated substantial loss on money invested by shareholders. ClearVue Technologies' management efficiency ratios could be used to measure how well ClearVue Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Kent Miller | Shoals Technologies Group | N/A | |
ACMA CGA | GCL Poly Energy Holdings | 69 | |
Markus Gloeckler | First Solar | 51 | |
Jeanna Steele | Sunrun Inc | 49 | |
Jie Wen | Xinyi Solar Holdings | 61 | |
Yuepeng Wan | GCL Poly Energy Holdings | 60 | |
Danny Abajian | Sunrun Inc | 40 | |
Xi Chen | Xinyi Solar Holdings | 65 | |
Jie Wen | Xinyi Solar Holdings | 61 | |
Mehgan Peetz | Shoals Technologies Group | 42 | |
Martin Fornage | Enphase Energy | 61 | |
Tianshi Lan | GCL Poly Energy Holdings | 42 | |
Karen Sagot | Enphase Energy | N/A | |
Michelle Philpot | Sunrun Inc | 57 | |
Xi Chen | Xinyi Solar Holdings | 65 | |
Dominic Bardos | Shoals Technologies Group | 60 | |
Man Li | Xinyi Solar Holdings | 68 | |
Man Li | Xinyi Solar Holdings | 68 | |
Mitchell Ennis | First Solar | N/A | |
Kay Tong | GCL Poly Energy Holdings | 76 | |
Michael Koralewski | First Solar | 53 |
Management Performance
Return On Equity | -0.21 | |||
Return On Asset | -0.13 |
ClearVue Technologies Leadership Team
Elected by the shareholders, the ClearVue Technologies' board of directors comprises two types of representatives: ClearVue Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ClearVue. The board's role is to monitor ClearVue Technologies' management team and ensure that shareholders' interests are well served. ClearVue Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ClearVue Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Tao Zhang, Technical Mang | ||
Geoffrey Edwards, Chief Officer | ||
Earle Harper, Chief Relations | ||
BCom AGIA, Company Sec | ||
BCom BCom, Company Sec | ||
Basil Karampelas, Chief America | ||
MPS Pharm, Founder Chairman |
ClearVue Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is ClearVue Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.21 | |||
Return On Asset | -0.13 | |||
Operating Margin | (13.91) % | |||
Current Valuation | 20.17 M | |||
Shares Outstanding | 217.06 M | |||
Shares Owned By Insiders | 37.96 % | |||
Price To Book | 2.08 X | |||
Price To Sales | 90.57 X | |||
Revenue | 287.61 K | |||
Gross Profit | (304.04 K) |
Currently Active Assets on Macroaxis
BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin | |
ADA | Cardano | |
XRP | XRP |
Other Information on Investing in ClearVue OTC Stock
ClearVue Technologies financial ratios help investors to determine whether ClearVue OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ClearVue with respect to the benefits of owning ClearVue Technologies security.